Ana Carolina Padula Ribeiro Pereira1, Rosalina Jorge Koifman2, Anke Bergmann3. 1. National School of Public Health, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil. Electronic address: carol_padula@hotmail.com. 2. National School of Public Health, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil. Electronic address: rosalina.koifman@hotmail.com. 3. National Cancer Institute, Rio de Janeiro, Brazil. Electronic address: abergmann@inca.gov.br.
Abstract
PURPOSE: To evaluate the incidence and risk factors of lymphedema 10 years after surgical treatment for breast cancer. METHODS: Prospective observational hospital-based cohort of women undergoing axillary lymph node dissection. Lymphedema was assessed by indirect volume, measured by circumference, and diagnosed if there was a difference of 200 mL between the arms or if the patient was treated for it. Independent variables were patient, tumour and treatment characteristics. Descriptive statistics were conducted as survival analysis using the Kaplan-Meier estimate. Cox regression was performed, considering a 95% confidence interval (95%CI). RESULTS: The study evaluated 964 women. The cumulative incidence of lymphedema observed was 13.5% at two years of follow-up, 30.2% at five years and 41.1% at 10 years. Final model showed an increased risk for lymphedema among women that underwent radiotherapy (HR = 2.19; 95%CI 1.63-2.94), were obese (HR = 1.52; 95%CI 1.20-1.92), had seroma formation after surgery (HR = 1.46; 95%CI 1.14-1.87), underwent chemotherapy infusion in the affected limb (HR = 1.45; 95%CI 1.12-1.87) or advanced disease staging (HR = 1.41; 95%CI 1.11-1.80). CONCLUSIONS: Cumulative incidence of lymphedema was 41.1%. Women undergoing axillary radiotherapy, obese, who developed seroma, underwent chemotherapy infusion in the affected limb and with advanced disease had a higher risk of lymphedema.
PURPOSE: To evaluate the incidence and risk factors of lymphedema 10 years after surgical treatment for breast cancer. METHODS: Prospective observational hospital-based cohort of women undergoing axillary lymph node dissection. Lymphedema was assessed by indirect volume, measured by circumference, and diagnosed if there was a difference of 200 mL between the arms or if the patient was treated for it. Independent variables were patient, tumour and treatment characteristics. Descriptive statistics were conducted as survival analysis using the Kaplan-Meier estimate. Cox regression was performed, considering a 95% confidence interval (95%CI). RESULTS: The study evaluated 964 women. The cumulative incidence of lymphedema observed was 13.5% at two years of follow-up, 30.2% at five years and 41.1% at 10 years. Final model showed an increased risk for lymphedema among women that underwent radiotherapy (HR = 2.19; 95%CI 1.63-2.94), were obese (HR = 1.52; 95%CI 1.20-1.92), had seroma formation after surgery (HR = 1.46; 95%CI 1.14-1.87), underwent chemotherapy infusion in the affected limb (HR = 1.45; 95%CI 1.12-1.87) or advanced disease staging (HR = 1.41; 95%CI 1.11-1.80). CONCLUSIONS: Cumulative incidence of lymphedema was 41.1%. Women undergoing axillary radiotherapy, obese, who developed seroma, underwent chemotherapy infusion in the affected limb and with advanced disease had a higher risk of lymphedema.
Authors: Gunel Guliyeva; Maria T Huayllani; Daniel Boczar; Francisco R Avila; Xiaona Lu; Antonio Jorge Forte Journal: J Cancer Surviv Date: 2021-01-24 Impact factor: 4.442
Authors: Fangdi Sun; Alexander Hall; Megan P Tighe; Cheryl L Brunelle; Hoda E Sayegh; Tessa C Gillespie; Kayla M Daniell; Alphonse G Taghian Journal: Breast Cancer Res Treat Date: 2018-07-30 Impact factor: 4.872
Authors: Antonio J Forte; Andrea Sisti; Maria T Huayllani; Daniel Boczar; Gabriela Cinotto; Pedro Ciudad; Oscar J Manrique; Xiaona Lu; Sarah McLaughlin Journal: Gland Surg Date: 2020-04
Authors: Anke Bergmann; Jaqueline Munaretto Timm Baiocchi; Luiz Claudio Santos Thuler Journal: Support Care Cancer Date: 2020-06-09 Impact factor: 3.603
Authors: Ann Marie Flores; Jason Nelson; Lee Sowles; Rebecca G Stephenson; Kathryn Robinson; Andrea Cheville; Antoinette P Sander; William J Blot Journal: Phys Ther Date: 2020-03-10
Authors: Crystal S Denlinger; Tara Sanft; K Scott Baker; Gregory Broderick; Wendy Demark-Wahnefried; Debra L Friedman; Mindy Goldman; Melissa Hudson; Nazanin Khakpour; Allison King; Divya Koura; Robin M Lally; Terry S Langbaum; Allison L McDonough; Michelle Melisko; Jose G Montoya; Kathi Mooney; Javid J Moslehi; Tracey O'Connor; Linda Overholser; Electra D Paskett; Jeffrey Peppercorn; William Pirl; M Alma Rodriguez; Kathryn J Ruddy; Paula Silverman; Sophia Smith; Karen L Syrjala; Amye Tevaarwerk; Susan G Urba; Mark T Wakabayashi; Phyllis Zee; Nicole R McMillian; Deborah A Freedman-Cass Journal: J Natl Compr Canc Netw Date: 2018-10 Impact factor: 11.908
Authors: Rebecca J Tsai; Leslie K Dennis; Charles F Lynch; Linda G Snetselaar; Gideon K D Zamba; Carol Scott-Conner Journal: Front Womens Health Date: 2018-05-31
Authors: Michelle J Naughton; Heshan Liu; Drew K Seisler; Jennifer Le-Rademacher; Jane M Armer; Jill M Oliveri; Jeffrey A Sloan; Karen Hock; Michael Schwartz; Gary Unzeitig; Marianne Melnik; Lisa D Yee; Gini F Fleming; John R Taylor; Charles Loprinzi; Electra D Paskett Journal: Cancer Date: 2020-10-20 Impact factor: 6.860